These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

389 related items for PubMed ID: 22810587

  • 1. APJ acts as a dual receptor in cardiac hypertrophy.
    Scimia MC, Hurtado C, Ray S, Metzler S, Wei K, Wang J, Woods CE, Purcell NH, Catalucci D, Akasaka T, Bueno OF, Vlasuk GP, Kaliman P, Bodmer R, Smith LH, Ashley E, Mercola M, Brown JH, Ruiz-Lozano P.
    Nature; 2012 Aug 16; 488(7411):394-8. PubMed ID: 22810587
    [Abstract] [Full Text] [Related]

  • 2. Apelin and APJ orchestrate complex tissue-specific control of cardiomyocyte hypertrophy and contractility in the hypertrophy-heart failure transition.
    Parikh VN, Liu J, Shang C, Woods C, Chang AC, Zhao M, Charo DN, Grunwald Z, Huang Y, Seo K, Tsao PS, Bernstein D, Ruiz-Lozano P, Quertermous T, Ashley EA.
    Am J Physiol Heart Circ Physiol; 2018 Aug 01; 315(2):H348-H356. PubMed ID: 29775410
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Endogenous regulation of cardiovascular function by apelin-APJ.
    Charo DN, Ho M, Fajardo G, Kawana M, Kundu RK, Sheikh AY, Finsterbach TP, Leeper NJ, Ernst KV, Chen MM, Ho YD, Chun HJ, Bernstein D, Ashley EA, Quertermous T.
    Am J Physiol Heart Circ Physiol; 2009 Nov 01; 297(5):H1904-13. PubMed ID: 19767528
    [Abstract] [Full Text] [Related]

  • 5. Possible involvement of downregulation of the apelin-APJ system in doxorubicin-induced cardiotoxicity.
    Hamada J, Baasanjav A, Ono N, Murata K, Kako K, Ishida J, Fukamizu A.
    Am J Physiol Heart Circ Physiol; 2015 Apr 15; 308(8):H931-41. PubMed ID: 25681427
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The microRNA-204-5p inhibits APJ signalling and confers resistance to cardiac hypertrophy and dysfunction.
    Gaddam RR, Kim YR, Jacobs JS, Yoon JY, Li Q, Cai A, Shankaiahgari H, London B, Irani K, Vikram A.
    Clin Transl Med; 2022 Jan 15; 12(1):e693. PubMed ID: 35060347
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Apela Regulates Fluid Homeostasis by Binding to the APJ Receptor to Activate Gi Signaling.
    Deng C, Chen H, Yang N, Feng Y, Hsueh AJ.
    J Biol Chem; 2015 Jul 24; 290(30):18261-8. PubMed ID: 25995451
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Apelin-13 increases myocardial progenitor cells and improves repair postmyocardial infarction.
    Li L, Zeng H, Chen JX.
    Am J Physiol Heart Circ Physiol; 2012 Sep 01; 303(5):H605-18. PubMed ID: 22752632
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.